← Back to signals
BSX
LONGINSIDER BUYBOSTON SCIENTIFIC CORP
Funds
3
Score
4.50
vs SPY
-39.3%
Stock return (since Q-end)
-23.0%
SPY return (since Q-end)
+16.3%
Current price
$48.31
News Summary
NegativeBoston Scientific reported Q1 2026 earnings that beat consensus but triggered significant guidance cuts, lowering FY2026 organic growth from 10-11% to 6.5-8% and reducing revenue guidance by ~$700M due to unexpected weakness in EP, WATCHMAN, and Urology segments. A securities class action lawsuit alleges material misstatements about EP business conditions, and the stock has declined 31% YTD with analyst price targets cut by 28% on average, reflecting sustained competitive and operational headwinds.
Red flags
- •FY2026 organic growth guidance slashed from 10-11% to 6.5-8% and full-year revenue cut by ~$700M (~3.2%)
- •WATCHMAN franchise flagged as potentially stagnating with flat sequential revenue expected in Q2-Q3
- •EP (electrophysiology) business showing competitive share losses and market softness despite prior claims of sustained high growth
- •Securities class action lawsuit alleging material misstatements about EP business and FARAPULSE platform performance between July 2025-Feb 2026
- •Stock down 31% YTD and down 17.6% on single day (Feb 4, 2026) following EP growth revelation
- •Five named executives listed in fraud suit including CEO Michael Mahoney and CFO Jonathan Monson
- •Multiple analyst downgrades and average price target reduction of 28% in past 3 months; Wells Fargo and Daiwa moved to Equal Weight/Neutral
- •Margin pressure cited from tariffs and reimbursement headwinds; hospital capacity constraints affecting key franchises
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | QoQ | Status |
|---|---|---|---|---|---|---|
| Maverick Capital | Lee Ainslie | 4.2M | +4.2M | $263.2B | — | NEW |
| Point72 | Steve Cohen | 3.7M | +3.7M | $231.4B | — | NEW |
| Lone Pine Capital | Steve Mandel | 105K | +105K | $6.6B | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|
| Pegus Cheryl | — | BUY | 2K | $56.49 | $0.10M | 2026-05-20 |
| LUDWIG EDWARD J | — | BUY | 4K | $56.68 | $0.20M | 2026-05-20 |
| Habiger David C | — | BUY | 2K | $55.92 | $0.13M | 2026-05-20 |
| Habiger David C | — | BUY | 2K | $56.95 | $0.13M | 2026-05-19 |